Advertisement

Masthead

        Advances in Chronic Kidney Disease (ISSN 1548-5595) is published quarterly by Elsevier. (For Post Office use only: Volume 13 issue 1 of 4). Months of issue are January, April, July, and October. Periodicals postage paid at Orlando, FL 32862, and additional mailing offices. Corporate and Editorial Offices: 1600 John F. Kennedy Boule-vard, Suite 1800, Philadelphia, PA 19103-2899. Accounting and Circulation Offices: 6277 Sea Harbor Dr, Orlando, FL 32887-4800.
        POSTMASTER: Send change of address to Advances in Chronic Kidney Disease, Elsevier, Periodicals Department, 6277 Sea Harbor Dr, Orlando, FL 32887-4800.
        Editorial correspondence should be addressed to Wendy Weinstock Brown, MD, MPH, DVA Tennessee Valley Healthcare System, 1310 24th Avenue South, Nashville, TN, 37212; e-mail: [email protected] .
        Correspondence regarding subscriptions or change of address should be directed to the Publisher, Elsevier, Periodicals Department, 6277 Sea Harbor Dr, Orlando, FL 32887-4800.
        Change of address notices, including both the old and new addresses of the subscriber and the mailing label, should be sent at least one month in advance.
        Customer Service: (800) 654-2452; outside the United States and Canada, (407) 345-4000.
        Yearly subscription rates: United States and possessions: individuals, $184.00; institution, $232.00; students and residents, $111.00; single issues, $67.00. All other countries: individuals, $216.00; institutions, $265.00; students and residents, $136.00; single issues, $67.00. For all areas outside the United States and possessions, there is no additional charge for air speed delivery. To receive student/resident rate, orders must be accompanied by name of affiliated institution, date of term, and the signature of program/residency coordinator on institution letterhead. Orders will be billed at individual rate until proof of status is received.
        Prices are subject to change without notice. Current prices are in effect for back volumes and back issues. Single issues, both current and back, exist in limited quantities and are offered for sale subject to availability. Back issues sold in conjunction with a subscription are on a prorated basis. Checks should be made payable to Elsevier and sent to Advances in Chronic Kidney Disease, Elsevier, Periodicals Department, P.O. Box 628239, Orlando, FL 32862-8239.
        Copyright © 2006 National Kidney Foundation, Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means now or hereafter known, electronic or mechanical, including photocopy, recording, or any information storage and re-trieval system, without permission in writing from the Publisher. Printed in the United States of America.
        Correspondence regarding permission to reprint all or part of any article published in this journal should be addressed to Elsevier’s Rights Department in Philadelphia, PA, USA: phone 215-239-3804, fax 215-239-3805, e-mail [email protected] . Requests may also be completed on-line via the Elsevier homepage (www.elsevier.com/locate/permissions).
        The appearance of the code at the bottom of the first page of an article in this journal indicates the copyright owner’s consent that copies of the article may be made for personal or internal use, or for the personal or internal use of specific clients, for those registered with the Copyright Clearance Center, Inc. (222 Rosewood Drive, Danvers, MA 01923; (508) 750-8400; www.copyright.com). This consent is given on the condition that the copier pay the stated per-copy fee for that article through the Copyright Clearance Center, Inc. for copying beyond that permitted by Sections 107 or 108 of the US Copyright Law. This consent does not extend to other kinds of copying, such as copying for general distribution, for advertising or promotional purposes, for creating new collective works, or for resale. Absence of the code indicates that the material may not be processed through the Copyright Clearance Center, Inc.
        Reprints: Reprint inquiries should be addressed to Anne Rosenthal, Elsevier Inc., Commercial Reprints, 360 Park Avenue South, New York, NY 10010. Telephone (212) 633-3813, fax (212) 633-3820; e-mail: [email protected] .
        Advertising representative: Cunningham Associates, 180 Old Tappan Rd, Old Tappan, NJ 07675. Telephone: (201) 767-4170, Fax: (201) 767-8065.
        The ideas and opinions expressed in Advances in Chronic Kidney Disease do not necessarily reflect those of the National Kidney Foundation, the Editor, or the Publisher. Publication of an advertisement or other product mentioned in Advances in Chronic Kidney Disease should not be construed as an endorsement of the product or the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The National Kidney Foundation and the Publisher do not assume any responsibility for any injury and/or damage to persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other health care professional, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.
        The contents of Advances in Chronic Kidney Disease are indexed in Index Medicus and MEDLINE, Current Contents/Clinical Medicine, Science Citation Index, EMBASE/Excerpta Medica, ISI, and CINAHL.
        The Advances in Chronic Kidney Disease home page is located at www.ackdjournal.org.